Latest Boehringer Ingelheim Stories
DiabetesSisters has received joint funding from Boehringer-Ingelheim and Eli Lilly in the amount of $50,0000 to support the creation of DiabetesSisters’ first Educational Library.
New choice between mist and dry powder inhalers for tiotropium RIDGEFIELD, Conn., Jan. 21, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has exercised an option to receive exclusive rights to
HEIDELBERG, Germany, January 5, 2015 /PRNewswire/ -- BioMed X announced today that they have entered into a collaboration agreement with Boehringer Ingelheim to establish
- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Dec.
- Retrospective analysis of more than 38,000 patients shows PRADAXA is associated with lower rates of stroke and major bleeding compared to warfarin RIDGEFIELD, Conn., Nov.
- totally perplexed and mixed up.